SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $36,000 | +12.5% | 12,200 | -64.8% | 0.00% | -50.0% |
Q2 2020 | $32,000 | +113.3% | 34,700 | +191.6% | 0.00% | +300.0% |
Q1 2020 | $15,000 | +1400.0% | 11,900 | +15.5% | 0.00% | – |
Q4 2019 | $1,000 | -75.0% | 10,300 | -9.6% | 0.00% | -100.0% |
Q3 2019 | $4,000 | -66.7% | 11,400 | -2.6% | 0.00% | -50.0% |
Q2 2019 | $12,000 | -29.4% | 11,700 | +17.0% | 0.00% | -71.4% |
Q4 2018 | $17,000 | -70.7% | 10,000 | -35.9% | 0.01% | -53.3% |
Q3 2018 | $58,000 | – | 15,600 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |